ABO blood group and the risk of hepatocellular carcinoma: A case-control study in patients with chronic hepatitis B

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Li, Qiang ^a   Yu, Cui Hua ^a   Yu, Jin Hong ^a   Liu, Li ^a   Xie, Shuang Shuang ^a   Li, Wen Wen ^b   Yang, Xia ^c   Fan, Wen Bo ^d   Gai, Zhong Tao ^a   Chen, Shi Jun ^a   Kato, Naoya ^b  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF TOKYO   (Japan)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^d Unit of Digestive Disease   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD GROUP A; BLOOD GROUP ABO SYSTEM; BLOOD GROUP B; BLOOD GROUP O; CANCER RISK; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE DOSAGE; HEPATITIS B; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SEX DIFFERENCE; BLOOD; CASE CONTROL STUDY; LIVER TUMOR; MIDDLE AGED; RISK;

HEPATITIS B VIRUS;

ABO BLOOD-GROUP SYSTEM; ADULT; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RISK;

EID: 84855317642     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029928     Document Type: Article

References (51)

1. Bosch FX, Ribes J, Diaz M, Cleries R, (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127: S5-S16.
2. Sherman M, (2010) Hepatocellular carcinoma: New and emerging risks. Dig Liver Dis 42 (Suppl 3): S215-222.
3. El-Serag HB, Rudolph KL, (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576.
4. Zhou XD, Tang ZY, Yang BH, Lin ZY, Ma ZC, et al. (2001) Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer 91: 1479-1486.
5. Fattovich G, Stroffolini T, Zagni I, Donato F, (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127: S35-50.
6. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, et al. (2002) Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 347: 168-174.
7. Chen CJ, Yang HI, Su J, Jen CL, You SL, et al. (2006) Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295: 65-73.
8. Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, et al. (2008) Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 100: 1134-1143.
9. Yu MC, Yuan JM, (2004) Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 127: S72-78.
10. Abu Dayyeh BK, Yang M, Fuchs BC, Karl DL, Yamada S, et al. (2011) A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma. Gastroenterology 141: 141-149.
11. Jeng JE, Tsai JF, Chuang LY, Ho MS, Lin ZY, et al. (2007) Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia 9: 987-992.
12. Tanabe KK, Lemoine A, Finkelstein DM, Kawasaki H, Fujii T, et al. (2008) Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA 299: 53-60.
13. Greenwell P, (1997) Blood group antigens: molecules seeking a function? Glycoconj J 14: 159-173.
14. Pare G, Chasman DI, Kellogg M, Zee RY, Rifai N, et al. (2008) Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet 4: e1000118.
15. Melzer D, Perry JR, Hernandez D, Corsi AM, Stevens K, et al. (2008) A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet 4: e1000072.
16. Park EJ, Lee JH, Yu GY, He G, Ali SR, et al. (2010) Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140: 197-208.
17. Shimizu Y, Minemura M, Tsukishiro T, Kashii Y, Miyamoto M, et al. (1995) Serum concentration of intercellular adhesion molecule-1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis. Hepatology 22: 525-531.
18. Meigs JB, Hu FB, Rifai N, Manson JE, (2004) Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 291: 1978-1986.
19. Song Y, Manson JE, Tinker L, Rifai N, Cook NR, et al. (2007) Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women. Diabetes 56: 1898-1904.
20. El-Serag HB, Hampel H, Javadi F, (2006) The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 4: 369-380.
21. Zohrens G, Armbrust T, Pirzer U, Meyer zum Buschenfelde KH, Ramadori G, (1993) Intercellular adhesion molecule-1 concentration in sera of patients with acute and chronic liver disease: relationship to disease activity and cirrhosis. Hepatology 18: 798-802.
22. Moriyama M, Matsumura H, Shioda J, Aoki H, Nakamura H, et al. (2006) Measurement of human intercellular adhesion molecule 1 in the blood is useful for predicting the occurrence of hepatocellular carcinomas from chronic hepatitis C and liver cirrhosis. Intervirology 49: 327-338.
23. Li Q, Li WW, Yu JH, Liu L, Chen SJ, (2007) Association of Type 2 Diabetes and HBeAg Negative with Noncirrhotic Hepatocellular Carcinoma[Abstract]. Hepatol Int 1: O-314.
24. Yang Y, (2002) Chinese Food Compostion Table 2002. Peking Peking University Medical Presss.
25. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ, (1994) Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19: 1513-1520.
26. Leevy CM, Sherlock S, Tygstrup N, Zetterman R, (1994) Diseases of the Liver and Biliary Tract: Standardization of Nomenclature, Diagnostic Criteria, and Prognosis New York: Raven Press pp. 61-62.
27. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R, (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60: 646-649.
28. Poujol-Robert A, Boelle PY, Wendum D, Poupon R, Robert A, (2006) Association between ABO blood group and fibrosis severity in chronic hepatitis C infection. Dig Dis Sci 51: 1633-1636.
29. Trevisani F, Caraceni P, Bernardi M, D'Intino PE, Arienti V, et al. (1993) Gross pathologic types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental, and clinical factors. Cancer 72: 1557-1563.
30. Terada T, Nakanuma Y, (1991) Expression of ABH blood group antigens, receptors of Ulex europaeus agglutinin I, and factor VIII-related antigen on sinusoidal endothelial cells in adenomatous hyperplasia in human cirrhotic livers. Hum Pathol 22: 486-493.
31. Okada Y, Arima T, Togawa K, Nagashima H, Jinno K, et al. (1987) Neoexpression of ABH and Lewis blood group antigens in human hepatocellular carcinomas. J Natl Cancer Inst 78: 19-28.
32. Barbalic M, Dupuis J, Dehghan A, Bis JC, Hoogeveen RC, et al. (2010) Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet 19: 1863-1872.
33. Engelmann B, Schumacher U, Haen E, (1992) Epidermal growth factor binding sites on human erythrocytes in donors with different ABO blood groups. Am J Hematol 39: 239-241.
34. Paterson AD, Lopes-Virella MF, Waggott D, Boright AP, Hosseini SM, et al. (2009) Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol 29: 1958-1967.
35. Berasain C, Perugorria MJ, Latasa MU, Castillo J, Goni S, et al. (2009) The epidermal growth factor receptor: a link between inflammation and liver cancer. Exp Biol Med (Maywood) 234: 713-725.
36. Hakomori S, (1999) Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta 1473: 247-266.
37. Schattenberg JM, Schuchmann M, Galle PR, (2011) Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways. J Gastroenterol Hepatol 26 (Suppl 1): 213-219.
38. Leeuwenberg JF, Smeets EF, Neefjes JJ, Shaffer MA, Cinek T, et al. (1992) E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology 77: 543-549.
39. Schram MT, Chaturvedi N, Schalkwijk C, Giorgino F, Ebeling P, et al. (2003) Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care 26: 2165-2173.
40. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA, (1988) Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 52: 925-933.
41. Polgar J, Matuskova J, Wagner DD, (2005) The P-selectin, tissue factor, coagulation triad. J Thromb Haemost 3: 1590-1596.
42. Lotan R, Raz A, (1988) Endogenous lectins as mediators of tumor cell adhesion. J Cell Biochem 37: 107-117.
43. Ripoche J, (2011) Blood platelets and inflammation: their relationship with liver and digestive diseases. Clin Res Hepatol Gastroenterol 35: 353-357.
44. Lu SN, Wang JH, Liu SL, Hung CH, Chen CH, et al. (2006) Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Cancer 107: 2212-2222.
45. Afdhal N, McHutchison J, Brown R, Jacobson I, Manns M, et al. (2008) Thrombocytopenia associated with chronic liver disease. J Hepatol 48: 1000-1007.
46. Otto VI, Damoc E, Cueni LN, Schurpf T, Frei R, et al. (2006) N-glycan structures and N-glycosylation sites of mouse soluble intercellular adhesion molecule-1 revealed by MALDI-TOF and FTICR mass spectrometry. Glycobiology 16: 1033-1044.
47. Ravn V, Dabelsteen E, (2000) Tissue distribution of histo-blood group antigens. APMIS 108: 1-28.
48. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, et al. (2008) Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 359: 1995-2004.
49. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, et al. (2007) Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317: 121-124.
50. Evans AA, Chen G, Ross EA, Shen FM, Lin WY, et al. (2002) Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 11: 369-376.
51. Hassan MM, Kaseb A, Li D, Patt YZ, Vauthey JN, et al. (2009) Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology 49: 1563-1570.